Malin Corporation PLC Notice of 2022 AGM & Directorate Change (2648J)
26 Abril 2022 - 3:02AM
UK Regulatory
TIDM0Y71
RNS Number : 2648J
Malin Corporation PLC
26 April 2022
Malin Corporation plc
Notice of 2022 AGM & Directorate Change
Dublin-Ireland, 26 April 2022 : Malin Corporation plc. (Euronext
Growth Dublin:MLC) ("Malin", the "Company"), a company investing in
highly innovative life sciences companies, announces that the
Letter from the Chair, Notice of Annual General Meeting ("AGM") and
Form of Proxy have been issued to shareholders. An electronic copy
of all documents is also available on the Company's website at
www.malinplc.com.
Malin's 2022 AGM will be held in the Conrad Dublin Hotel,
Earlsfort Terrace, Dublin 2, D02 V562, Ireland at 10:00am Irish
Standard Time/BST on Friday, 27 May 2022.
The Notice of AGM sets out the resolutions to be proposed at the
AGM and the processes by which shareholders may vote in connection
with the AGM.
In addition, a teleconference facility will be available to any
shareholders not in physical attendance at the AGM to listen
remotely to the proceedings of the meeting, using the following
details:
From Ireland dial: 01 5369584
From the UK dial: 020 3936 2999
From the USA dial: 1 646 664 1960
From other locations dial: +44 20 3936 2999
Listen-Only Access Code: 015280
The Company also announces that Christopher Pedrick (45) has
been appointed to the board of directors of Malin and Luke Corning
has resigned from the board, both with immediate effect. Mr Pedrick
is head of the Equity Capital Markets Group at Pentwater Capital
Management LP group ("Pentwater"). Pentwater holds 28.6% of the
Issued Ordinary Share Capital of Malin. Prior to joining Pentwater,
Mr Pedrick held a number of senior investment management positions
in the UK and US. He has a B.A. in Economics from Dartmouth
College.
Regulatory disclosures
Other than as set out above, there are no other matters required
to be disclosed pursuant to the Euronext Growth Markets Rule Book
as regards the appointment of Christopher Pedrick.
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) is a company investing in
highly innovative life sciences companies. Its purpose is to create
shareholder value through the application of long--term capital and
operational and strategic expertise to a diverse range of global
healthcare businesses. Malin has a focus on innovative businesses
underpinned by exceptional science and works with its investee
companies, providing strategic and financial support to enable them
to reach their value potential. Malin is headquartered and
domiciled in Ireland and listed on the Euronext Growth Dublin. For
more information visit www.malinplc.com .
For further information, please contact:
Malin
Fiona Dunlevy, Company Secretary
Tel: +353 (0)1 901 5700
cosec@malinplc.com
Davy Corporate Finance (Euronext Growth Listing Sponsor &
Joint Broker)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
Liberum (Joint Broker)
Phil Walker / Ben Cryer
Tel: +44 (0) 20 3100 2000
Powerscourt (Irish media enquiries)
Eavan Gannon
Tel: +353 87 236 5973
malin@powerscourt--group.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOASELFMIEESESL
(END) Dow Jones Newswires
April 26, 2022 02:02 ET (06:02 GMT)
Malin (LSE:0Y71)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Malin (LSE:0Y71)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025